nfr-logonfr-logo
PROJECT BANK
Switch to English
Statistics
Projects

0 projects

Date from new to old

EIC-The European Innovation Council (EIC)

NEXT GENERATION IMAGING FOR REAL-TIME DOSE VERIFICATION ENABLING ADAPTIVE PROTON THERAPY

NEXT GENERATION IMAGING FOR REAL-TIME DOSE VERIFICATION ENABLING ADAPTIVE PROTON THERAPY

Awarded: NOK 17.8 mill.

Project Period: 2024-2028

Location: Vestland

EIC-The European Innovation Council (EIC)

Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.

Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.

Awarded: NOK 25.2 mill.

Project Period: 2024-2028

Location: Oslo

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Human - Centric Indoor Climate for Healthcare Facilities

Over 4 million hospital patients acquire a healthcare-associated infection (HAI) in the EU each year. Moreover, the global crisis of antimicrobial resistance means that HAI is posing an increasing cost and risk of mortality. There is clear evidence that airflow controls the dispersion and exposur...

Awarded: NOK 9.0 mill.

Project Period: 2024-2027

Location: Trøndelag - Trööndelage

CL1-Health

Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers

Perioperative care is an intricate process that encompasses 1) preoperative evaluation, surgical planning and preparation; 2) intraoperative procedure; and 3) postoperative management. Perioperative care depends on clinical decision-making, a continuous process that involves many healthcare profe...

Awarded: NOK 44.6 mill.

Project Period: 2024-2027

Location: Trøndelag - Trööndelage og 2 andre

MSCA-Marie Sklodowska-Curie Actions (MSCA)

DSTrain - Data Science Postdoctoral Training Programme

DSTrain is a 5-year postdoctoral programme that will award 36 postdoctoral fellowship positions of 36 months each in two calls over the programme period within the overarching frame of data science. The programme will train researchers and innovators with disciplinary, interdisciplinary and trans...

Awarded: NOK 52.1 mill.

Project Period: 2024-2028

Location: Rogaland og 12 andre

CL1-Health

ENTEROVIRUS-LINKED TYPE 1 DIABETES EXPOSED -MECHANISMS AND PREVENTION

ENTEROVIRUS-LINKED TYPE 1 DIABETES EXPOSED -MECHANISMS AND PREVENTION

Awarded: NOK 7.3 mill.

Project Period: 2024-2027

Location: Oslo

CL1-Health

The first European Digital Health Technology Assessment framework co-created by all stakeholders along the value chain

Digital health technologies (DHTs) are expected to improve both the quality and delivery of healthcare services for European societies while ensuring the sustainability of Europe`s healthcare systems. DHTs are also able to collect real-world data and evidence relevant for decision makers. However...

Awarded: NOK 21.5 mill.

Project Period: 2024-2027

Location: Akershus og 2 andre

CL1-Health

The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomics

The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomics

Awarded: NOK 12.2 mill.

Project Period: 2024-2028

Location: Oslo

CL1-Health

Development of a global diagnostic ecosystem for detecting and monitoring emergency-prone pathogens across species and in a unified way

Development of a global diagnostic ecosystem for detecting and monitoring emergency-prone pathogens across species and in a unified way

Awarded: NOK 9.4 mill.

Project Period: 2023-2027

Location: Vestland

CL1-Health

Targeting Epstein-Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis

Targeting Epstein-Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis

Awarded: NOK 29.6 mill.

Project Period: 2023-2028

Location: Vestland og 5 andre

CL5-Climate, Energy and Mobility

From solar energy to fuel: A holistic artificial photosynthesis platform for the production of viable solar fuels

From solar energy to fuel: A holistic artificial photosynthesis platform for the production of viable solar fuels

Awarded: NOK 21.8 mill.

Project Period: 2023-2027

Location: Oslo og 2 andre

CL1-Health

PREDICTION OF ALZHEIMER’S DISEASE USING AN AI DRIVEN SCREENING PLATFORM

PREDICTION OF ALZHEIMER’S DISEASE USING AN AI DRIVEN SCREENING PLATFORM

Awarded: NOK 11.9 mill.

Project Period: 2023-2027

Location: Rogaland

ERC-European Research Council (ERC)

Targeting Acute Leukemia with TdT-TCR-T-cell therapy

The aim of this PoC project is to commercialize new therapy for acute lymphoblastic leukemia (ALL) developed in context of my ERC consolidator grant. T-cell receptors (TCRs) have in recent years emerged as promising therapeutic molecules in cell- and gene-therapy of cancer. I have completed the p...

Awarded: NOK 1.7 mill.

Project Period: 2023-2025

Location: Oslo og 2 andre

CL1-Health

PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials

Millions of people in the EU are negatively affected by cancer, and cancer is one of the leading causes of death and morbidity in Europe (ecis.jrc.europa.eu). The PRIME-ROSE consortium will contribute to the Mission Cancer goal to optimise treatment and support quality of life of more than 3 mill...

Awarded: NOK 18.2 mill.

Project Period: 2023-2028

Location: Oslo

CL1-Health

Reconstruction and Computational Modelling for Inherited Metabolic Diseases

Reconstruction and Computational Modelling for Inherited Metabolic Diseases

Awarded: NOK 0.10 mill.

Project Period: 2023-2027

Location: Oslo

CL1-Health

TOWARDS LARGE-SCALE ADAPTION AND TAILORED IMPLEMENTATION OF EVIDENCE-BASED PRIMARY CANCER PREVENTION PROGRAMMES IN EUROPE AND BEYOND

TOWARDS LARGE-SCALE ADAPTION AND TAILORED IMPLEMENTATION OF EVIDENCE-BASED PRIMARY CANCER PREVENTION PROGRAMMES IN EUROPE AND BEYOND

Awarded: NOK 1.8 mill.

Project Period: 2023-2027

Location: Vestland

CL1-Health

COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

Awarded: NOK 3.2 mill.

Project Period: 2023-2026

Location: Oslo

CL1-Health

IMPlementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older bReasT cAncer patieNTs

IMPlementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older bReasT cAncer patieNTs

Awarded: NOK 3.7 mill.

Project Period: 2023-2028

Location: Akershus

CL1-Health

International Study for Treatment of Childhood Relapsed ALL 2020

Relapse of acute lymphoblastic leukemia (ALL) remains a leading cause of mortality in childhood cancer. IntReALL 2020 will conduct randomized and historically controlled trials in children with relapsed B-cell precursor (BCP) ALL with the aim to replace toxic chemotherapy with better tolerated an...

Awarded: NOK 1.1 mill.

Project Period: 2023-2028

Location: Oslo

CL1-Health

Establishing of Cancer Mission Hubs: Networks and Synergies

Establishing of Cancer Mission Hubs: Networks and Synergies

Awarded: NOK 3.7 mill.

Project Period: 2023-2026

Location: Oslo og 3 andre

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Guiding glioblastoma treatments by decrypting tumor biomechanics via Magnetic Resonance Elastography.

Guiding glioblastoma treatments by decrypting tumor biomechanics via Magnetic Resonance Elastography.

Awarded: NOK 2.9 mill.

Project Period: 2023-2026

Location: Oslo

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Combination therapy for the treatment of metastatic melanoma using magnetic nanoparticles

Combination therapy for the treatment of metastatic melanoma using magnetic nanoparticles

Awarded: NOK 3.0 mill.

Project Period: 2023-2027

Location: Oslo

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Determining Genetic Bases of Differential Response to Antipsychotics Using Patient-Derived Neurons

Schizophrenia (SCZ) affects 20 million people worldwide and antipsychotics remain the only effective pharmacological intervention. However, one-third of people with SCZ do not respond to first-line antipsychotic drugs. In the absence of clinical biomarkers to stratify SCZ subtypes, all individual...

Awarded: NOK 3.1 mill.

Project Period: 2023-2025

Location: Vestland

WIDENING-Widening participation and spreading excellence

Diabetes, obesity and the Kidney

Chronic kidney disease is a major cause of morbidity and mortality in the EU. About 10-15% of the EU population has chronic kidney disease (CKD) and this number is expected to increase in the future decades. Diabetes is today the main cause of CKD in the EU: about, 30% of the cases with dialysi...

Awarded: NOK 2.9 mill.

Project Period: 2023-2025

Location: Oslo

ERC-European Research Council (ERC)

Final act of the autophagy symphony: Whole-organism orchestration of autophagy termination

When an organism experiences physiological stresses, such as nutrient starvation, it activates several mechanisms to promote its survival. One of these mechanisms is autophagy, which is a catabolic pathway conserved from yeast to man that functions as a recycling system during normal physiology, ...

Awarded: NOK 15.2 mill.

Project Period: 2023-2027

Location: Oslo

CL1-Health

CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE

Rare tumour risk syndromes (RTRS) are rare diseases, affecting 5 per 10.000 people or less and caused by heritable genetic variants. In RTRS, the lifetime risk to develop various cancers can be as high as 100%, and patients have a 50% chance of transmitting the disease to their offspring. When un...

Awarded: NOK 3.5 mill.

Project Period: 2023-2025

Location: Vestland

CL1-Health

Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

Awarded: NOK 7.6 mill.

Project Period: 2023-2026

Location: Oslo

CL1-Health

Maximising Impact of Prescription Drugs in Rheumatoid Arthritis

Maximising Impact of Prescription Drugs in Rheumatoid Arthritis

Awarded: NOK 21.1 mill.

Project Period: 2022-2027

Location: Oslo

EIC-The European Innovation Council (EIC)

Supervised morphogenesis in gastruloids

The lack of realistic in vitro organ models that can faithfully represent in vivo physiological processes is a major obstacle affecting the biological and medical sciences. The current gold standard is animal experiments, but it is increasingly clear that these models mostly fail to recapitulate ...

Awarded: NOK 13.6 mill.

Project Period: 2022-2027

Location: Oslo

CL1-Health

Fostering a European Research Area for Health Research

Fostering a European Research Area for Health Research

Awarded: NOK 15.8 mill.

Project Period: 2022-2029

Location: Vestland og 2 andre

12345